Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
NCT04675320
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
BIOLOGICAL:
blood samples
Sponsor
Centre Georges Francois Leclerc